03.05.2013
- Eli Lilly, the world's fourth-largest diabetes drugs maker, aims to have the widest range of anti diabetic drugs in order to win a larger slice in the growing market. The global...
03.05.2013
- Is nanomedicine the next big thing? A growing number of top drug companies seem to think so. The ability to encapsulate potent drugs in tiny particles measuring billionths of a...
02.05.2013
- Sanofi is stepping up the development of a fixed combination of diabetes treatments Lantus and Lyxumia to sidestep an earlier setback with a similar pen device and take advantage...
01.05.2013
- Denmark's Novo Nordisk could see the U.S. launch of its biggest drug hope, a new long-acting insulin, delayed until 2018 while it conducts more tests to satisfy regulators, it said...
30.04.2013
- Zoetis, formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer, posted a stronger-than-expected quarterly profit, driven by growth in sales of pet products in...
25.04.2013
- Biogen reported higher-than-expected first quarter profit on Thursday and raised its full year forecasts, and the U.S. biotechnology said it sees its new drug Tecfidera becoming...
12.04.2013
- U.S. investment firm Royalty Pharma is considering sweetening its $6.6 billion offer for Irish drugmaker Elan by paying Elan shareholders more if the multiple sclerosis drug...
11.04.2013
- The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...
22.03.2013
- European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...
19.03.2013
- Drug sales will shrink further in France this year as government austerity measures curb healthcare spending in Europe's second-biggest drugs market, a study said on Tuesday. The...